Sunshine Act

The Sunshine Act was passed as part of the Accountable Care Act and mandated transparent accounting of all fund transfers from industry to physicians. We are in full agreement with this law as it better allows you (our patients) to better assess potential conflicts of interest that may be present. As most of you know, our core mission at Rocky Mountain MS Research Group is to advance the science of MS therapeutics as well as improve the safety of existing agents. Doing this requires a constructive collaboration with industry, as this is where new drug development takes place. We are excited to be involved in advising industry, administering trials, and discussing best practices and drug safety with physicians on a commercial basis. Innovation in therapeutics cannot occur without this relationship, and we will continue to do our part to help eradicate the scourge of multiple sclerosis.

We will post on this website our financial relationships as soon as the information is available to us. The bulk of this money is utilized to carry out research and support the employees and infrastructure necessary to our mission. As always, feel free to ask us any questions that might arise.